Hepatitis C virus escape studies for human antibody AR3A reveals a high barrier to resistance and novel insights on viral antibody evasion mechanisms

    Rodrigo Velázquez-Moctezuma
    Rodrigo Velázquez-Moctezuma

    Journal of virology, 2018.

    Cited by: 0|Bibtex|Views1|Links
    WOS

    Abstract:

    Yearly ∼2 million people become hepatitis C virus (HCV) infected, resulting in elevated life-time risk for severe liver-related chronic illnesses. Characterizing epitopes of broadly neutralizing antibodies (NAbs), such as AR3A, is critical to guide vaccine development. Previously identified alanine substitutions reducing AR3A binding to e...More

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments